
|Videos|June 26, 2021
Dr. Ariana Matz on trends in priapism malpractice litigation
Author(s)Urology Times staff
“We found that medications allegedly causing priapism and the litigation surrounding that is significant because it means that the patient-physician relationship was not well established,” says Ariana Matz, MD.
Advertisement
In this video, Ariana Matz, MD, of New York Medical College, Valhalla, discusses the Urology study, “Review of priapism litigation in the United States,” for which she served as a study author.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












